Read next
AI-Designed Biomolecules Advance to Phase II Clinical Trials
Biopharmaceutical firms report accelerated pre-clinical validation timelines for computationally generated small-molecule candidates.
GLP-1 Supply Shortages Accelerate Production Line Automation
Pharmaceutical manufacturers are deploying automated fill-finish capacity to meet surging global demand for weight-loss therapeutics.
Mental Health Apps: What the Evidence Supports
Thousands of apps, a small number with real trials behind them. The distinction is not visible in the…
Clinical Data Validates Generative AI in De Novo Protein Design
Phase I trials confirm safety profiles for novel therapeutic proteins generated via deep learning algorithms.
Pharmaceutical Supply Chains Restructure Around Biomanufacturing Resilience
Drug manufacturers increase localized manufacturing facilities to mitigate single-source API vulnerabilities.
Continuous Glucose Monitors Expand Beyond Diabetes into Clinical Preventative Care
Regulatory clearances and declining sensor unit costs are accelerating adoption in metabolic monitoring programs.